AtriCure Inc. (ATRC) Plunges 6.91% on October 19

AtriCure Inc. (ATRC) Plunges 6.91% on October 19

AtriCure Inc. (ATRC) had a rough trading day for Friday October 19 as shares tumbled 6.91%, or a loss of $-2.25 per share, to close at $30.29. After opening the day at $32.46, shares of AtriCure Inc. traded as high as $32.59 and as low as $30.24. Volume was 259,472 shares over 1,903 trades, against an average daily volume of 229,067 shares and a total float of 35.36 million.

As a result of the decline, AtriCure Inc. now has a market cap of $1.07 billion. In the last year, shares of AtriCure Inc. have traded between a range of $36.49 and $14.88, and its 50-day SMA is currently $33.16 and 200-day SMA is $25.02.

AtriCure Inc is a medical device company. It develops, manufactures and sells cardiac surgical ablation systems designed to create precise lesions, scars in cardiac, heart, and tissue. It generates revenue by selling disposable surgical devices.

AtriCure Inc. is based out of Mason, OH and has some 570 employees. Its CEO is Michael H. Carrel.

AtriCure Inc. is a component of the Russell 2000. The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It’s maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell’s indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It’s a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

error: Content is protected !!